|
|
Article: Peginterferon alfa-2B studies show positive data in treatment of hepatitis C.
- Article from:
- Clinical Trials Week
- Article date:
- November 29, 2004
CopyrightCOPYRIGHT 2004 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
2004 NOV 29 - (NewsRx.com & NewsRx.net) -- Data from two ongoing studies testing new approaches for the treatment of chronic hepatitis C were presented at the annual meeting of the American Association for the Study of Liver Diseases (AASLD).
Presented by principal investigator Nezam Afdhal, MD, chief of hepatology at Beth Israel Deaconess Medical Center (BIDMC) and associate professor of medicine at Harvard Medical School, the new findings provide researchers with sufficient evidence to demonstrate promising results for hepatitis C patients who have not responded to existing therapies.
A viral infection, hepatitis C is transmitted through exposure to ...